Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs.
2004
490
LTM Revenue $140M
LTM EBITDA $34.4M
$245M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Vireo Growth has a last 12-month revenue of $140M and a last 12-month EBITDA of $34.4M.
In the most recent fiscal year, Vireo Growth achieved revenue of $61.2M and an EBITDA of $11.8M.
Vireo Growth expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Vireo Growth valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $51.8M | $61.2M | $96.7M | $140M | XXX |
Gross Profit | $13.7M | $21.5M | $30.6M | XXX | XXX |
Gross Margin | 27% | 35% | 32% | XXX | XXX |
EBITDA | -$6.9M | $11.8M | $23.9M | $34.4M | XXX |
EBITDA Margin | -13% | 19% | 25% | 25% | XXX |
Net Profit | -$23.4M | -$29.5M | -$17.7M | XXX | XXX |
Net Margin | -45% | -48% | -18% | XXX | XXX |
Net Debt | $8.5M | $29.8M | $37.1M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 14, 2025, Vireo Growth's stock price is CAD 1 (or $0).
Vireo Growth has current market cap of CAD 252M (or $175M), and EV of CAD 353M (or $245M).
See Vireo Growth trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$245M | $175M | XXX | XXX | XXX | XXX | $-0.09 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 14, 2025, Vireo Growth has market cap of $175M and EV of $245M.
Vireo Growth's trades at 2.5x LTM EV/Revenue multiple, and 10.2x LTM EBITDA.
Analysts estimate Vireo Growth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Vireo Growth and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $245M | XXX | XXX | XXX |
EV/Revenue | 2.5x | XXX | XXX | XXX |
EV/EBITDA | 10.2x | XXX | XXX | XXX |
P/E | -10.4x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpVireo Growth's NTM/LTM revenue growth is 4%
Vireo Growth's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $48K for the same period.
Over next 12 months, Vireo Growth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Vireo Growth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Vireo Growth and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 58% | XXX | XXX | XXX | XXX |
EBITDA Margin | 25% | XXX | XXX | XXX | XXX |
EBITDA Growth | 102% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 28% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $48K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 36% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 38% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vireo Growth acquired XXX companies to date.
Last acquisition by Vireo Growth was XXXXXXXX, XXXXX XXXXX XXXXXX . Vireo Growth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Vireo Growth founded? | Vireo Growth was founded in 2004. |
Where is Vireo Growth headquartered? | Vireo Growth is headquartered in Canada. |
How many employees does Vireo Growth have? | As of today, Vireo Growth has 490 employees. |
Is Vireo Growth publicy listed? | Yes, Vireo Growth is a public company listed on CNQ. |
What is the stock symbol of Vireo Growth? | Vireo Growth trades under VREO ticker. |
When did Vireo Growth go public? | Vireo Growth went public in 2005. |
Who are competitors of Vireo Growth? | Similar companies to Vireo Growth include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
What is the current market cap of Vireo Growth? | Vireo Growth's current market cap is $175M |
What is the current revenue of Vireo Growth? | Vireo Growth's last 12-month revenue is $140M. |
What is the current EBITDA of Vireo Growth? | Vireo Growth's last 12-month EBITDA is $34.4M. |
What is the current EV/Revenue multiple of Vireo Growth? | Current revenue multiple of Vireo Growth is 2.5x. |
What is the current EV/EBITDA multiple of Vireo Growth? | Current EBITDA multiple of Vireo Growth is 10.2x. |
What is the current revenue growth of Vireo Growth? | Vireo Growth revenue growth between 2023 and 2024 was 58%. |
Is Vireo Growth profitable? | Yes, Vireo Growth is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.